Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules

International Journal of Cardiology

Volumn 139, Issue 2, 2010, Pages 150-158

  Lekakis, John ^a   Ikonomidis, Ignatios ^a   Papoutsi, Zoi ^b   Moutsatsou, Paraskevi ^b   Nikolaou, Maria ^a   Parissis, John ^a   Kremastinos, Dimitrios Th ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Adhesion molecules; Endothelial cells; Selective serotonin reuptake inhibitors

Indexed keywords

CITALOPRAM; FLUOXETINE; FLUVOXAMINE; INTERCELLULAR ADHESION MOLECULE 1; SERTRALINE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CELL ADHESION; CELL STRAIN U937; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; HEART PROTECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MAJOR CLINICAL STUDY; MONOCYTE; PRIORITY JOURNAL;

ADULT; AGED; AORTA; CELL ADHESION; CELL SURVIVAL; CHRONIC DISEASE; CITALOPRAM; DEPRESSION; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUOXETINE; FLUVOXAMINE; HEART FAILURE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MIDDLE AGED; MONOCYTES; PLACEBOS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 77249092687     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.10.010     Document Type: Article

References (35)

1. Frasure-Smith N., Lesperance F., and Talajic M. Depression following myocardial infarction:impact on 6-month survival. JAMA 270 (1993) 1819-1825
2. Bush D.E., Ziegelstein R.C., Tayback M., et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 88 (2001) 337-341
3. Carney R.M., Rich M.W., Tevelde A., Saini J., Clark K., and Jaffe A.S. Major depressive disorder in coronary artery disease. Am J Cardiol 60 (1987) 1273-1275
4. Musselman D.L., Evans D.L., and Nemeroff C.B. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 55 (1998) 580-592
5. Rajagopalan S., Brook R., Rubenfire M., Pitt E., Young E., and Pitt B. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol 88 (2001) 196-198
6. Sherwood A., Hinderliter A.L., Watkins L.L., Waugh R.A., and Blumenthal J.A. Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J Am Coll Cardiol 46 (2005) 656-659
7. Sauer W.H., Berlin J.A., and Kimmel S.E. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 104 (2001) 1894-1898
8. Glassman A.H., O'Connor C.M., Calliff R.M., et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288 (2002) 701-709
9. Serebruany V.L., Suckow R.F., Cooper T.B., et al. Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. Am J Psychiatry 162 (2005) 1165-1170
10. Blankenberg S., Rupprecht H.J., Bickel C., et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 104 (2001) 1336-1342
11. Ikonomidis I., Stamatelopoulos K., Lekakis J., Vamvakou G.D., and Kremastinos D.T. Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease. Atherosclerosis 199 1 (2008) 3-11
12. Himmerich H., Fulda S., Linseisen J., et al. Depression, comorbidities and the TNF-alpha system. Eur Psychiatry 23 (2008) 421-429
13. Parissis J.T., Adamopoulos S., Rigas A., et al. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am J Cardiol 15 94 (2004) 1326-1328
14. Wu D., Koga T., Martin K.R., and Meydani M. Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes. Atheroslerosis 147 2 (1999) 297-307
15. Zhang W.J., and Frei B. Albumin selectively inhibits TNF alpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res 55 4 (2002) 820-829
16. Zhang W.J., Stocker R., McCall M.R., Forte T.M., and Frei B. Lack of inhibitory effect of HDL on TNF alpha-induced adhesion molecule expression in human aortic endothelial cells. Atheroslerosis 165 2 (2002) 241-249
17. Denizof F., and Lang R. Rapid colorimetric assay for cell growth and survival: modifications to the tetrozolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89 2 (1986) 271-277
18. Maurer Spurej E. Serotonin reuptake inhibitors and cardiovascular diseases: a platelet connection CMLS. Cell Mol Life Sci 62 (2005) 159-170
19. Zapolska-Downar D., Zapolski-Downar A., Markiewski M., Ciechanowicz A., Kaczmarczyk M., and Naruszewicz M. Selective inhibition by α-tocopherol of vascular cell adhesion molecule-1 expression in human vascular endothelial cells. Biochem Biophys Res Comm 274 (2000) 609-615
20. Parissis J.T., Nikolaou M., Farmakis D., et al. Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure. Heart 94 (2008) 585-589
21. Nieminen M.S., Bohm M., Cowie M.R., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 384-416
22. Zung W.W. A self-rating depression scale. Arch GenPsychiatry 12 (1965) 63-70
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
24. Monaco C., and Paleolog E. Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis. Cardiovasc Res 61 4 (2004) 671-682
25. Glibetic M., Samlalsingh-Parker J., Raykova V., Ofenstein J., and Aranda J.V. Group B Streptococci and inducible nitric oxide synthase: modulation by nuclear factor kappa B and ibuprofen. Semin Perinatol 25 2 (2001) 65-69
26. Vo P.A., Lad B., Tomlinson J.A., Francis S., and Ahluwalia A. Autoregulatory role of endothelium-derived nitric oxide (NO) on lipopolysaccharide-induced vascular inducible NO synthase expression and function. J Biol Chem 280 8 (2005) 7236-7243
27. Stefano G.B., and Peter D. Cell surface estrogen receptors coupled to cNOS mediate immune and vascular tissue regulation: therapeutic implications. Med Sci Monit 7 (2001) 1066-1074
28. Lara N., Archer S.L., Baker G.B., and LeMelledo J.M. Paroxetine-induced increase in metabolic end-products of nitric oxide. J Clin Psychopharmacol 23 (2003) 641-645
29. Khan B.V., Harrisson D.G., Olbrych M.T., Alexander R.W., and Medford R.M. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci USA 93 (1996) 9114-9118
30. Frishman W.H. Biologic markers as predictors of cardiovascular disease. Am J Med 104 6A (1998) 18S-27S
31. Marfella R., Esposito K., Giunta R., et al. Circulating adhesion molecules in humans. Role of hyperglycemia and hyperinsoulinemia. Circulation 101 (2000) 2247-2251
32. Joannides R., Haefeli W.E., Linder L., et al. Nitric oxide is responsible for flow-dependent dilation of human peripheral conduit arteries in vivo. Circulation 91 (1995) 1314-1319
33. Zouridakis E., Avangas P., Arroyo-Espliguero R., Fredericks S., and Kaski J.C. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 110 (2004) 1747-1753
34. Koh K.K., Han S.H., and Quon M.J. Inflammatory markers and the metabolic syndrome. Insights from therapeutic interventions. J Am Coll Cardiol 46 (2005) 1978-1985
35. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150